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KESAN-KESAN TEKNIK PENGHANTARAN SEL SECARA EROSOL KE 
ATAS REGENERASI DAN PEMBAIKAN EPITELIUM PERNAFASAN 
 
ABSTRAK 
 
Teknologi penghantaran sel berasaskan erosol telah muncul sebagai satu 
kaedah strategi terapeutik yang berpotensi dalam mengatasi kelemahan pembaikan 
dalam kapasiti trakea serta paru-paru selepas kecederaan. Objektif kajian ini adalah 
untuk menentukan kesan penghantaran sel epitelia pernafasan (AEC) berasaskan 
erosol ke atas proses pemulihan dan rawatan trakea, kerosakan paru-paru, dan respon 
keradangan setempat dalam kecederaan paru-paru akut (ALI) yang disebabkan oleh 
teknik pemberusan pada trakea arnab. AEC berasal dari trakea arnab putih New 
Zealand. Penghantaran sel dengan teknik in vitro dilakukan untuk menilai keupayaan 
sel untuk hidup. Teknik pemberusan pada trakea dilakukan adalah bertujuan untuk 
mencederakan lapisan epitelium peparu. Sehari selepas kecederaan, sel AEC arnab 
yang telah di label dengan BrdU dihantar ke dalam trakea yang cedera menggunakan 
MicroSprayer® Aerosolizer. Penilaian ke atas keselamatan dan ketoksikan telah 
dilakukan bagi memerhati tindakbalas haiwan terhadap rawatan sel. Penilaian 
histopatologi bagi kecederaan trakea dan paru-paru serta respon keradangan setempat 
dan sistemik telah diukur secara kuantitatif dalam tempoh sehari dan lima hari selepas 
penghantaran sel. Dua kultur in vitro telah dilakukan untuk menentukan kesan fungsi 
AEC ke atas proses pemulihan dan rawatan trakea. Dalam kondisi tekanan erosol, AEC 
mampu mengekalkan keupayaan untuk hidup tanpa kesan ke atas ciri-ciri morfologi 
serta menunjukkan kebolehupayaan proliferasi yang tinggi. Teknik pemberusan pada 
trakea arnab telah mengakibatkan gangguan pada struktur dan komposisi sel epitelium 
trakea serta kerosakan alveolar terserap yang mencerminkan ciri-ciri ALI. 
Penghantaran sel AEC secara erosol merupakan suatu prosedur yang selamat kerana 
xxiii 
 
tiada penolakan pada peringkat sel dan membawa kepada peningkatan di dalam 
regenerasi dan pembaikan epitelium di trakea, pemulihan respon keradangan pada 
kerosakan paru-paru. Mekanisme utama yang mendasari kesan terapeutik yang positif 
adalah disebabkan oleh sebatian yang dirembeskan oleh AEC. Kajian ini memberikan 
pandangan tentang teknologi penghantaran sel berasaskan erosol secara selular dan 
molekular, teknik ini akan menjadi asas untuk terapi masa hadapan bagi merawat 
kecederaan paru-paru.   
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THE FFFECTS OF AEROSOL-BASED CELL DELIVERY TECHNIQUE ON 
THE REGENERATION AND REPAIR OF AIRWAY EPITHELIUM 
 
ABSTRACT 
 
Aerosol-based cell delivery is a potential therapeutic strategy to overcome the 
debilitating reparative capacity of trachea and lung following injury. The goal of this 
study was to determine the effect of aerosol-based airway epithelial cell (AEC) 
delivery on tracheal repair and regeneration, lung damage, and local inflammatory 
responses in the setting of acute lung injury (ALI) induced by tracheal brushing in 
rabbit. AECs were isolated from the trachea of New Zealand white rabbits. In vitro 
aerosol delivery was performed to assess the viability of the cells. Brushing-induced 
tracheal injury was performed in a rabbit model to develop ALI. One day following 
injury, exogenous BrdU-labelled AECs were aerosolized using the MicroSprayer® 
Aerosolizer into the injured airway. Assessment involving safety and toxicity were 
carried out to observe the animal responses towards cell treatment. Histopathological 
assessments of the injury in the trachea and lungs along with local and systemic 
inflammatory responses were quantitatively measured at one and five days after cell 
delivery. Two in vitro co-culture assays were performed to investigate the functional 
effect of AECs on tracheal regeneration and repair. Under aerosol pressure, AECs were 
able to maintain a high viability rate without affecting their morphological features 
and proliferative capability compared. Brushing-induced tracheal injury exfoliated 
tracheal epithelium layer and triggered alveolar damage-associated ALI. Following 
treatment, aerosol-based AEC delivery appeared to be a safe procedure and positively 
modulate tracheal epithelium repair and regeneration, reduce inflammation, and 
attenuate lung injury in the rabbit model of ALI. The key mechanisms underlying this 
positive impact is due to the secretory factors that were released by AEC. This study 
xxv 
 
provides cellular and molecular insights of aerosol-based cellular therapy to form a 
basis evidence for future therapy to treat lung injuries. 
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CHAPTER I 
GENERAL INTRODUCTION 
 
1.1 Anatomy of the respiratory airway 
1.1.1 The branching of respiratory airway 
The lung is made up of a complex branching networks of airway (Metzger et 
al., 2008). Respiratory tree structure goes from the larger airways branch into smaller 
airways until reaches the surface of the lung (Whittemore, 2009). The airway provides 
a pathway for the air to flow in and out from the lung periphery, while alveoli perform 
the gas exchange. Based on this concept, the lung is divided into two general zones: 
the conducting zones and the respiratory zone (Figure 1.1).  
The conducting zone comprises upper (nasal cavity, pharynx and larynx) and 
lower (trachea, bronchi and bronchioles) respiratory tract (Iwasaki et al., 2017). The 
trachea bifurcates into two main stem bronchi that further subdivide into bronchioles 
(Hickey, 2007). Meanwhile, oesophagus is positioned directly posterior to the cervical 
part of the trachea and typically extends slightly to the left of the intrathoracic part 
(Sasson et al., 2003). The respiratory zone begins with respiratory bronchioles that 
continue to subdivide into alveolar ducts and finally alveolar sacs (Hickey, 2007). This 
zone represents about 85% of the total lung volume, whereas the conducting airway 
zone covers only about 6 to 10%. The remaining part, in addition, consists of nervous 
and vascular tissue (Gehr, 1984). 
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Figure 1.1 Schematic of the human respiratory system. Respiratory airway is divided into two general zones, the conducting zones and the respiratory zone 
(Adapted from (Kleinstreuer et al., 2008)).
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1.1.2 The cellular structure of respiratory airway 
1.1.2(a) Trachea and main bronchi 
Trachea consists of a single tube with a C-shaped cartilage rings that are 
connected posteriorly by smooth muscle and connective tissue (Hickey, 2007). It is 
positioned midline in the neck and facilitated the passage of air between the larynx and 
the lungs (Sasson et al., 2003). Cartilage is composed of chondrocytes and only present 
surrounding the trachea and bronchi (Pérez, 2007). The first cartilage rings is broader 
than the rest of the tracheal rings and partly recessed into the cricoid cartilage (Sasson 
et al., 2003). The purpose of cartilage tissue is to retain the epithelium and to prevent 
the trachea from collapsing due to extreme circumstances such as coughing and forced 
expiration (Whittemore, 2009). 
Pseudostratified epithelium consists of ciliated, basal, secretory/goblet, and 
neuroendocrine cells that line the basement membrane of the trachea and main stem 
bronchi. (Knight and Holgate, 2003, Roomans, 2010) (Figure 1.2a). Ciliated cells are 
the predominant cell type in the trachea and bronchi and a terminally differentiated 
cell population (Rawlins and Hogan, 2008) that expressed keratin 8 (K8) and 18 (K18) 
(Cole et al., 2010). Secretory/goblet cells, indeed, produce and secrete mucus (Rock et 
al., 2010) that marked by the expression of transcription factor SAM Pointed Domain 
Containing ETS Transcription Factor (SPDEF) and mucin-5ac (Muc5ac) (Kotton and 
Morrisey, 2014). Together with ciliated cells, both cells are responsible for driving the 
process of mucocilary clearance (Holtzman et al., 2014). Ciliated cells and secretory 
cells are considered as the luminal epithelial cells that constitute the barrier defence in 
larger airways (Gizurarson, 2012, Iwasaki et al., 2017). These luminal cells are in 
direct contact with microbes and particles that must be removed or accommodated to 
prevent their access to underlying epithelial cells (Whitsett and Alenghat, 2015). When 
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a pathogen manages to enter the airway, goblet cells secrete mucins in a gel-like form 
and create a barrier that bind bacterial/microbial pathogens from adhering to the 
conducting airways (Voynow and Rubin, 2009). The removal of particles and 
pathogens from the airway is called mucociliary clearance that orchestrated by ciliated 
cells’ sweeping motion (Gizurarson, 2012, Holtzman et al., 2014). Basal cells are 
located at the base of pseudostratified epithelium, rich of hemidesmosomes, and 
characterized by the expression of transcription factor-63 (p63), K5, K14, and Nerve 
Growth Factor Receptor (NGFR) (Rock et al., 2009, Kotton and Morrisey, 2014, 
Weiss et al., 2015). These cells are defined as an ‘anchor’ to the pseudostratified 
epithelium due to the fact that they provide the major stem/progenitor cell function 
that are capable of giving rise to ciliated and secretory cells (Cole et al., 2010, Hackett 
et al., 2011, Crystal, 2014, Weiss et al., 2015).  
 
1.1.2(b) Bronchiole 
In more distal airways, cartilage disappears and is replaced by smooth muscles 
that surrounds the bronchiole epithelium (Whittemore, 2009). The bronchiole region 
is lined with a monolayer simple cuboidal epithelium that consist of secretory/club 
(formerly known as Clara cells), ciliated, and neuroendocrine epithelial cells (Kotton 
and Morrisey, 2014) (Figure 1.2b). A few basal cells are also present in the distal 
airway, however they gradually diminish in number distally (Hamid et al., 2005). 
Neuroendocrine cells are commonly clustered in neuroendocrine bodies (NEBs) that 
express calcitonin gene–related peptide (CGRP) (Kotton and Morrisey, 2014). These 
cells are generally found along the proximal bronchioles and the bronchoalveolar duct 
junction (BADJ) of terminal bronchioles (Snyder et al., 2009). The secretory/club 
cells, meanwhile, are defined as non-ciliated, columnar cells that contain abundant 
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endoplasmic reticulum and dense secretory granules (secretoglobin (Scgb)) 
(Nettesheim et al., 1990, Rokicki et al., 2016). The club cells are commonly marked 
by the expression of Scgb1a1 and Scgb3a2 (Reynolds et al., 2002). Similar to the upper 
airway epithelium, the bronchiole epithelium is also in quiescent state until activated 
by injury (Kotton and Morrisey, 2014).  
 
1.1.2(c) Alveoli 
Alveoli are the site for exchanging respiratory gases (Whittemore, 2009). The 
alveoli permit gas exchange by providing structure and thin air-surface barriers for 
oxygen diffusion into the capillary (Herring et al., 2014). Mature alveoli are made up 
of two major distinct epithelial cell types, ATI and ATII (Figure 1.2C). ATI is a flat 
squamous epithelial cells that cover >95% of the gas exchange surface (Yang et al., 
2016). The cells are surrounded by a thin cytoplasm (Fraser, 2005, Hamid et al., 2005, 
Whittemore, 2009) and identified by the expression of Podoplanin (Pdpn) and HOP 
Homeobox (HOPX) (Jain et al., 2015). The thin and flat shape of ATI facilitate their 
close contact with capillaries to perform gas exchange (Jain et al., 2015). Meanwhile, 
ATII is cuboidal in shape with round nucleus and produces surfactant protein such as 
Prosurfactant Protein C (ProSPC) that is stored in specialized lamellar bodies (Jain et 
al., 2015). These cells also regulate the alveolar lining fluid to support alveolar surface 
tension and prevent alveolar collapse (Fehrenbach, 2001, Manzer et al., 2006, Desai et 
al., 2014). ATI cells are generally considered terminally differentiated (Yang et al., 
2016), while ATIIs are called the “stem cells” of the alveoli because of their ability to 
self-renew and give rise to ATI (Kotton and Morrisey, 2014).  
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Figure 1.2 Epithelial cell type in the conducting airways (nasal, trachea, bronchi, and 
bronchiole) and respiratory airways (alveoli). a) Tracheobronchial of the proximal 
cartilaginous airway are lined with a pseudostratified epithelium that consist of ciliated, basal, 
and secretory/goblet cells, b) In the more distal airways, the bronchiole region lined with a 
simple cuboidal epithelium consisting of ciliated, basal, and secretory/club cells, and c) gas-
exchanging airspace (alveolar region) consisted of two major distinct epithelial cell types, ATI 
and ATII. Adapted from (Wetsel et al., 2011). 
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1.1.3 Lung stem cells niche 
The ability of lungs to maintain itself and repair after injury is dependent on 
the activity of endogenous lung stem cells. These lung stem cells respond to exogenous 
cues from the niche, a surrounding environment of local tissue (Hegab et al., 2015, 
Donne et al., 2015). The function of the niche is to control long-term maintenance of 
lung stem cell as well as to influence the stem cell to self-renew and/or differentiate 
into the appropriate lineages (Volckaert and De Langhe, 2014, Savukinas et al., 2016). 
This behaviour of lung stem cells depends on the integration with other cell signals 
and direct contact with the underlying extracellular matrix (ECM) as well as with 
neighbouring epithelial cells (Volckaert and De Langhe, 2014). 
Epithelial cell lining provides structural integrity and is the first line of defence 
against the external environment to the respiratory airway by their intracellular 
junctional proteins and secretory products (Blanpain et al., 2007, Whitsett and 
Alenghat, 2015). The loss of these cells due to wear and tear, inflammation, or injury 
requires the presence of stem cells to constantly reconstitute the epithelium lining. The 
process this continuous cell replacement is called tissue homeostasis and is critical for 
adult tissue maintenance (Blanpain et al., 2007). Adult stem cell is defined as cell from 
adult tissues that are multipotent and have the capacity for long term self-renewal and 
differentiation into the cell lineages of their tissue of origin (Weiss et al., 2015). 
Studies in human and animal lung defined subsets of lung epithelial cells with self-
renewal and proliferative capacity, including basal (Hong et al., 2004b, Hajj et al., 
2007, Cole et al., 2010, Rock et al., 2011, Crystal, 2014, Pardo-Saganta et al., 2015), 
club cells (Plopper et al., 1992, Stripp and Reynolds, 2008, Rawlins et al., 2009) of the 
tracheobronchial tree, and ATII cells (Fehrenbach, 2001, Barkauskas et al., 2013, Zeng 
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et al., 2016) of the alveoli. Under normal homeostasis, these cells are functioned as 
stem cells that give rise to airway epithelial cell lineages. 
In the proximal region, studies have shown the potential of K5+ K14+ basal cell 
to proliferate and differentiate into secretory and ciliated epithelial cells in response to 
chlorine- (Musah et al., 2012), naphthalene- (Hong et al., 2004b) and cystic fibrosis-
induced airway injury (Voynow et al., 2005) Another study also demonstrated that 
basal cells generate a multipotent p63- K8+ luminal cells that includes secretory and 
ciliated cells after exposure to sulphur dioxide (Rock et al., 2011). In vitro, basal cells 
from the mouse trachea that expressed p63+, Nerve Growth Factor Receptor (NGFR+), 
and K5+ underwent self-renewal and generate ‘tracheospheres’ that contained both 
ciliated and secretory cells (Rock et al., 2009). 
In the distal bronchioles, club cells are more abundant than ciliated cells 
(Morrisey and Hogan, 2010), while basal cells are gradually diminish in number. 
Therefore, club cells in the bronchiole region are the cell population that maintains the 
facultative progenitor cell pool (self-renewal) and give rise to ciliated cells of the 
airway epithelium. According to a few studies, proliferative club cells that express 
Clara cell secretory protein (CCSP) were identified at the terminal bronchiolar region 
and capable of epithelial renewal after naphthalene-induced injury (Reynolds et al., 
2000, Hong et al., 2001, Giangreco et al., 2002). A study also suggested a rise of stem 
cell population in the bronchioalveolar duct junctions that expressed both club cell 
(Scgb1a1 and CC10) and ATII cell marker following naphthalene-induced injury 
(proSPC) (Kim et al., 2005), therefore indicating a combination of two stem cell 
population in the terminal bronchioalveolar region. 
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Meanwhile, ATII cells are endogenous stem cell population in the alveoli 
region and have the ability to self-renew and give rise to ATI during both lung 
development and repair after injury. Rock et al. investigated that proSPC+ ATII cells 
are multipotent progenitors for the alveolar epithelium that give rise to ATI cells under 
steady state conditions, after bleomycin injury, and post-pneumonectomy (Rock et al., 
2011). It is believed that when injured, ATI cells secreted an epidermal growth factor 
(EGF) that activated ATII to differentiate into ATI cells (Desai et al., 2014). In vitro, 
ATII cell culture has been proven to have the ability of forming a three-dimensional 
(3D) organoid culture called alveolospheres that comprised both ATII cells and 
HOPX+ ATI cells (Barkauskas et al., 2013). 
Additional cell-cell contact and signalling is required to activate the local 
response as well as engaging this self-renewal and differentiation events in an attempt 
to restore airway structural and functional integrity (Pongracz and Stockley, 2006). 
Signal network such as Wnt signalling is essential and marked during early lung 
development (Okubo and Hogan, 2004, Cohen et al., 2009, Goss et al., 2009). Wnt 
signalling also has been implicated in the modulation of cell fate decisions and 
differentiation of lung cell types (Hogan et al., 2014, Frank et al., 2016). Studies have 
investigated that Wnt signal production is specific to lung cell types, for example, 
Wnt2 has been mapped predominantly to the mesenchyme (Monkley et al., 1996), 
while Wnt7b regulated epithelial and mesenchymal cell proliferation and also vascular 
development in the lung (Weidenfeld et al., 2002, Shu et al., 2002, Rajagopal et al., 
2008). It is therefore understandable that airway repair process is influenced by a 
combination of signalling from cells such as epithelial and/or their neighbouring cells.  
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The behaviour of lung stem cells also depends on the integration with the 
underlying ECM. The repair process of airway epithelium started with epithelial cell 
from neighbouring the wound receiving signals from the damage cells. The 
endogenous stem cells retrieve the signalling and respond to injury by cell migration, 
proliferation, and differentiation processes (Yahaya, 2012, Girault and Brochiero, 
2014), which are guided by the integrin-mediated cell adhesion to the ECM in the 
niche (Volckaert and De Langhe, 2014). Studies have reported that a reduced integrin 
and ECM expression in adherent cells triggers terminal differentiation of cultured 
epidermal stem cells (Grose et al., 2002, Watt, 2002).  
Together, these data suggest that lung stem cells are subjected to a tight 
regulatory process before they are activated and gave an appropriate regenerative 
response during tissue homeostasis, which involve a dynamic mechanism between 
stem cells and their niche. 
 
1.2 Lung disorders 
No organ is more vital and vulnerable than the lung. Lung diseases have 
become a major concern in medical care and causes an immense worldwide health 
burden. According to World Health Organization (WHO) statistics, non-
communicable diseases, including cardiovascular diseases, cancers, diabetes, and 
chronic lung diseases were responsible for almost 68% of all deaths worldwide in 
2012, which arise from 60% in 2000. In 2015, chronic obstructive pulmonary disease 
(COPD) alone was responsible for 3 million deaths worldwide. The rise of these non-
communicable diseases is mostly driven by excessive tobacco use, physical inactivity, 
the harmful use of alcohol, and unhealthy diets. Acute respiratory distress 
syndrome/acute lung injury (ARDS/ALI) is also a devastating disease spectrum that 
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associated with morbidity and mortality worldwide. ARDS cases, meanwhile, 
represent an incidence rate of nearly 9% of ventilated patients in Intensive Care Units 
(ICUs) (Roupie et al., 1999). In addition, mortality rate of patients with ARDS/ALI 
from 1994 to 2006 was 44.0% (From databases: MEDLINE, EMBASE, CINAHL, 
Cochrane CENTRAL) (Phua et al., 2009). 
 
1.2.1 Chronic lung injury 
Two major debilitating chronic lung injury are COPD and asthma. Exposure to 
tobacco smoke, allergens, infectious agents, and noxious gases can induce chronic 
injuries of airway epithelium. Asthma and COPD are both chronic inflammatory 
conditions of the conducting airways and lung parenchyma (Jeffery, 2001).  
 
1.2.1(a) Chronic obstructive pulmonary disease (COPD) 
Individuals with COPD commonly experience shortness of breath as well as 
increased coughing associated with increased sputum production and are prone to 
developing serious conditions, such as recurring chest infections, respiratory failure, 
pulmonary hypertension, and heart failure (Chung and Adcock, 2008). While cigarette 
smoking is the principal cause of COPD, chronic exposures to pollutants can also 
contribute to the development and/or exacerbation of COPD (Cosio and Guerassimov, 
1999). COPD is also associated with emphysema that is characterized by difficulties 
in breathing due to obstructed airflow (Mannino and Buist, 2007). Patients with 
emphysema have a loss of alveolar surface area available for gas exchange due to 
destruction of alveolar septa (Yoshida and Tuder, 2007). Other pathogenesis of COPD 
also includes inflammatory responses in the airway, loss of barrier function, alterations 
of cell growth, cellular apoptosis, abnormal cell repair, ECM destruction, and 
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oxidative stress. These features are important events in the pathogenesis of COPD 
(Yoshida and Tuder, 2007, Ryter et al., 2009). According to O’Donnell et al., COPD-
related histopathology has increased numbers of neutrophils, lymphocytes, and 
macrophages (O'Donnell et al., 2006). Neutrophils release tissue damaging enzymes 
such as elastase that can increase epithelial mucin protein expression (Fischer and 
Voynow, 2000). Meanwhile, macrophages produce oxidants and potentially 
destructive ECM proteases (Yoshida and Tuder, 2007). 
 
1.2.1(b) Asthma 
Asthma is a complex, chronic inflammatory lung disease that leads to 
symptoms such as coughing, wheezing and chest tightness (Lambrecht and Hammad, 
2012). Asthma is triggered as a response to various internal and external stimuli 
including airborne allergens, infection, exercise, cold air, smoke, beta blockers, and 
stress (Holgate, 2008). If left untreated, asthma can cause many more irreversible 
changes in lung tissue. This disorder is characterized by airway wall remodelling, 
airway smooth muscle contraction and hyperreactivity, increased mucus production, 
and inflammatory cell accumulation (Worgall et al., 2013). The walls of the 
conducting airways in asthma are usually thickened between 50 and 300% of normal 
and there is evidence of luminal narrowing (Jeffery, 2001). The thick appearance of 
airway wall is due to hyperplastic smooth-muscle cells and deposition of ECM 
components under the basement membrane (Evans et al., 2009, Lambrecht and 
Hammad, 2012). It is a common finding that epithelium of the nasal and lower airways 
in the patients that suffer from asthma are fragile and easily detach from the basement 
membrane (Lackie et al., 1997, Shahana et al., 2006). Biopsy sample from subjects 
with asthma often demonstrated a reduced/loss of epithelial adherent junctions (E-
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cadherin) expression possibly as a result of epithelial-mesenchymal transition (EMT) 
(Hackett et al., 2009). The loss of E-cadherin expression might be due to proteolytic 
activity of inhaled cigarette smoke (Olivera et al., 2007) and allergens originating in 
pollen (Runswick et al., 2007) or fungi (Chen et al., 2011). The local innate system of 
the body such as dendritic cells recognize the breach of inhaled allergens and 
coordinate the subsequent immune response as well as facilitating allergic 
sensitization towards asthma (Lambrecht and Hammad, 2012). 
 
1.2.2 Acute lung injury (ALI) 
Acute lung injury (ALI) is the less severe acute respiratory distress syndrome 
(ARDS) represents a spectrum of lung disease with multiple risk factors that trigger 
the acute onset of respiratory insufficiency (Walkey et al., 2012, Fanelli et al., 2013). 
The term of ARDS was first described by Ashbaugh and Petty in 1967, where it was 
described as “acute onset of tachypnoea, hypoxaemia, and loss of compliance” in 12 
patients after a variety of stimuli-induced injury such as gastric aspiration, sepsis, blunt 
trauma, and near-drowning (Ashbaugh et al., 1967). In 1994, the American-European 
Consensus Conference Committee refined the definition of ARDS to standardize 
clinical research trials for the disease. Bernard et al. stated that patients with an acute 
onset of respiratory failure and less severe hypoxaemia (defined by a ratio of the 
arterial oxygen partial pressure to fractional inspired oxygen) with no evidence of left 
atrial hypertension or pulmonary capillary pressure < 18 mmHg are considered to have 
ALI, whilst those with more severe hypoxaemia are considered to have ARDS 
(Bernard et al., 1994). In 2011, the European Society of Intensive Care Medicine with 
endorsement from the American Thoracic Society and the Society of Critical Care 
Medicine convened an international expert panel to revise the ARDS definition in 
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Berlin (coined as Berlin definition). The panel agreed to modify the term “acute lung 
injury” and replacing it with three levels of ARDS severity (mild, moderate, and 
severe) based on the oxygenation, timing of acute onset, chest radiographic, and wedge 
pressure criterion (Table 1.1). 
In clinical setting, the initial acute or exudative phase of ALI/ARDS is 
characterized by the rapid onset of dyspnoea, hypoxemia, respiratory failure, and 
bilateral infiltrates on chest radiograph that are consistent with pulmonary oedema. 
The pulmonary oedema is caused by the altered lung fluid balance that permits an 
influx of fluid and protein into the lung interstitial (Ware and Matthay, 2000, Ware 
and Matthay, 2005, Ware, 2006).  
The occurrence of ALI can be segregated into direct and indirect pathologies 
(Table 1.2). Direct pathology is triggered by the injurious agent that reaches the lungs 
through the airways or by trauma to the chest, whereas indirect pathology implied that 
the injurious agent arrived at the lungs through the bloodstream (Schraufnagel, 2014). 
According to a study by Brun-Buisson et al., indirect ALI is often encountered from 
sepsis (Brun-Buisson et al., 2004). Menezes et al. performed series of intraperitoneal 
injection or intratracheal instillation of lipopolysaccharide (LPS) into mice to compare 
the direct and indirect ALI in a mice model (Menezes et al., 2005). The results showed 
that insult directly into the tracheal epithelium yielded more pronounced inflammatory 
responses. Thus, direct insult into the lungs can cause a more susceptible injury and 
requires therapeutic interventions when compared to the indirect ALI. 
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Table 1.1 American–European Consensus Conference and Berlin definition of ALI and ARDS 
Characteristic The AECC definition 1994 The Berlin definition 2012 
Onset Acute 
Within 1 week of a known clinical insult or new or worsening respiratory 
symptoms 
Chest imaging 
Bilateral infiltrate on frontal chest 
radiograph 
Bilateral opacities (not fully explained by effusion, atelectasis, or nodules) 
Non-cardiogenic source of 
pulmonary oedema 
No clinical evidence of elevated 
left atrial pressure or a pulmonary 
capillary wedge pressure < 18 
mmHg 
Respiratory failure not fully explained by cardiogenic pulmonary oedema or 
volume overload 
Oxygenation 
ALI: PaO2/FiO2 < 300 mmHg 
ARDS: PaO2/FiO2 < 200 mmHg 
Mild ARDS: 200 mmHg < PaO2/FiO2 ≤ 300 mmHg with PEEP ≥5 cm H2O 
Moderate ARDS: 100 mmHg < PaO2/FiO2 ≤ 200 mmHg with PEEP ≥ 5 cm H2O 
Severe ARDS: PaO2/FiO2 ≤ 100 mmHg with PEEP ≥ 5 cm H2O 
Risk factor Not specified 
If none identified, then need to rule out cardiogenic oedema with additional data 
(e.g., echocardiography) 
(Adapted from Bernard et al. (1994), (Force, 2012)) 
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Table 1.2 Clinical conditions that are associated with ALI 
Direct triggers Indirect triggers 
Pneumonia Sepsis 
Gastric aspiration Trauma 
Pulmonary contusion Burn injury 
Pulmonary embolism Transfusion 
Smoke and toxic gas inhalation Bypass surgery 
Reperfusion injury Intoxication 
Near drowning Acute pancreatitis 
 Drug overdose (e.g. heroin) 
(Adapted from Ware (2006), Wheeler and Bernard (2007), Laycock and Rajah (2010), Perl et al. (2011)) 
 
1.2.2(a) Clinical treatment of ALI 
Patients diagnosed with ALI/ARDS with severe hypoxemia are usually treated 
with mechanical ventilation due to insufficient oxygenation. Mechanical ventilator is 
also known as ventilator, respirator, or breathing machine. This machine imitates the 
inflation and deflation of the lung to facilitate gas exchange and represents the standard 
of care for patients with ALI/ARDS (Marini, 2013). However, this treatment can 
extend the inflammatory response of ALI/ARDS and develop a risk towards more 
severe lung injury (Tremblay and Slutsky, 2006). The excessive tidal volumes and 
plateau pressure from the ventilator can also cause substantial harm to the lung such 
as alveolar distention as well as other organs (Pierson, 1988, Gajic et al., 2005, Slutsky, 
2005). Repeated lung expansion (opening and closing) is also considered as a major 
risk that contributes to ventilation-induced lung injury (VILI) (Rittayamai and 
Brochard, 2015). Some patients that suffer from ALI often progress to a more 
protracted phase of persistent respiratory failure that is characterized by persistent 
hypoxemia, decreased lung compliance, fibrosis, chronic inflammation, and partial 
resolution of pulmonary oedema (Ware, 2006). In addition, patients who survive ALI 
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have been shown to have a reduced health-related quality of life (Weinert et al., 1997) 
and persistent muscle weakening (Herridge et al., 2003). 
 
1.2.2(b) Pathophysiology of ALI 
ALI is a disorder of acute inflammation that causes disruption of the alveolar–
capillary membrane that includes lung endothelial and epithelial barriers (Figure 1.3). 
The pathophysiology of ALI can be divided conceptually into two histopathological 
phases, early exudative and fibroproliferative phase (Standiford and Ward, 2016).  
Exudative phase usually occurred at 12 to 24 hours until the first week post-
injury and is characterized by diffuse alveolar damage (DAD) (Castro, 2006, Beasley, 
2010). The characteristics of ALI during early exudative phase include loss of 
alveolar–capillary membrane integrity that causes flooding of the alveolar 
compartment with protein rich oedema fluid, neutrophils, cellular debris and 
inflammatory mediators (Matthay and Zimmerman, 2005, Barnett and Ware, 2011, 
Proudfoot et al., 2011), extensive necrosis of ATI cells, and the formation of protein-
rich hyaline membranes on a denuded basement membrane (Proudfoot et al., 2011) 
(Figure 1.3). This inflammatory milieu consists predominantly of activated neutrophils 
and alveolar macrophages, which secrete inflammatory mediators that disrupt 
epithelial fluid transport and impair surfactant production by ATII cells (Proudfoot et 
al., 2011). Cytokines that have been identified in ALI include IL-2, IL-6, IL-8, IL-10, 
IL-1β and its receptor antagonist IL-1ra, tumour necrosis factor-α (TNF-α), and the 
soluble TNF 1 and 2 receptors (Barnett and Ware, 2011). Following injury, 
upregulation of pro-inflammatory cytokines such as IL-1, IL-6, IL-8, and TNF-α 
occurs as a direct response. These cytokines are mostly released by alveolar 
macrophage to stimulate chemotaxis and activate neutrophils (Levitt et al., 2009). 
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Transepithelial neutrophil migration is an important feature of ALI because 
neutrophils are the primary perpetrators of inflammation. Excessive and prolonged 
activation of neutrophils contributes to basement membrane destruction and increased 
alveolar–capillary barrier permeability (Johnson and Matthay, 2010). This is because 
neutrophils releases elastase that degrade epithelial junctional proteins and have direct 
cytotoxic and apoptotic effects on the epithelium (Ginzberg et al., 2001, Martin et al., 
2005). Neutrophils migration from the circulation system involve tethering, slow 
rolling, modulation of adhesion strength, intraluminal crawling, and transcellular and 
paracellular migration (Ley et al., 2007). Tethering action is mediated by interactions 
between L (expressed on leukocytes), E (expressed on endothelial cells), and P-
selectins (expressed on endothelial cells and platelets). These selectins facilitate rolling 
of leucocytes along the endothelium to prepare for migration. The rolling is then 
followed by the margination and adhesion of the neutrophils on the endothelial surface. 
This process involves β1 and β2 integrins and endothelial adhesion molecule (ICAM-
1, VCAM, MAdCAM-1) and integrin (a4b1, a4b7). Transmigration of neutrophils is 
then mediated by ICAM-1 (through intracellular) and VCAM (through vascular) 
(Maniatis et al., 2008, Zemans et al., 2009). The breach of neutrophils into the 
interstitial and alveolar spaces increase the alveolar-capillary permeability that permits 
the influx of protein-rich fluid to cross the epithelial barrier into the airspaces of the 
lung (Johnson and Matthay, 2010). Besides I-CAM and TNF-α, the receptor for 
advanced glycation end-product (RAGE) is also a prominent marker for alveolar 
epithelial injury. TNF-α promotes disruption of endothelial cell junctions that leads to 
pulmonary oedema (Georgieva et al., 2007), whereas RAGE transmits pro-
inflammatory intracellular signal via NF-κB (Creagh-Brown et al., 2010). RAGE is a 
specific marker of lung epithelial damage since it is expressed on the basolateral 
19 
 
surface of ATI cells (Ware et al., 2004). Majority of these pro-inflammatory cytokines 
are secreted by monocytes, fibroblasts, and endothelial cells during ALI 
(Mukhopadhyay et al., 2006, Maniatis and Orfanos, 2008). 
Impaired and extensive epithelial injury can lead to a fibroproliferative phase 
of ALI. In adult human, this phase usually occurs between three to seven days 
following respiratory failure (Tomashefski, 1990), whereas in experimental animal, 
this phase appears one week after injury (Beasley, 2010, Matute-Bello et al., 2011). 
During this phase, mesenchymal cells proliferate and neovascularisation occur in the 
respiratory airway. The lung is also manifested with exuberant fibroblasts and 
myofibroblasts that synthesise excessive collagenous ECM (Luh and Chiang, 2007, 
Proudfoot et al., 2011). 
 
1.2.2(c) Animal model of ALI 
Matute-Bello et al. stated that it is not practical to incorporate these parameters 
in experimental studies that used small animals as a model since animals and humans 
have considerable physiological and anatomical differences (Matute-Bello et al., 
2011). The American Thoracic Society (Matute-Bello et al., 2011) has discussed a 
number of features that are required to assess ALI in small animal models within 24 
hours of exposure: i) Histological evidence of tissue injury should be summed in an 
injury score and identical to DAD, which includes infiltration of neutrophils, presence 
of proteinaceous debris in the alveolar or the interstitial space, formation of hyaline 
membranes, and thickening of the alveolar wall. ii) Alteration of the alveolar capillary 
barrier should be measured to assess any increase in lung water content and protein 
concentration in bronchoalveolar lavage (BAL) fluid. iii) An increased in the number 
of inflammatory response such as neutrophils, cytokines, and myeloperoxidase activity 
should be evaluated in the BAL fluid and lung tissue. iv) There should be evidence of 
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physiological dysfunction after exposure, including hypoxemia and an increased 
alveolar–arterial oxygen difference. Matute-Bello et al. also suggested that at least 
three of these main features should be in evidence to identify ALI model of 
experimental animals (Matute-Bello et al., 2011). 
 
 
Figure 1.3 Pathogenesis of ALI. ALI is characterized by sloughing of alveolar epithelial cells, 
formation of hyaline membranes, and migration of activated neutrophils across the alveolar-
capillary barrier into the interstitial region. The loss of the alveolar-capillary barrier integrity 
facilitates the accumulation of a protein-rich oedema and inflammatory cells. Endogenous 
cells secrete pro-inflammatory mediators that disrupt epithelial fluid transport and impair 
surfactant production by ATII cells. The interplay between inflammation and extravascular 
fibrin deposition increases hypoxaemia with acute inflammatory response (Adapted from 
Ware and Matthay (2000)). 
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1.2.2(d) Inhalation-induced injury model of ALI 
Inhalation of reactive gases and vapours such as naphthalene and sulphur 
dioxide (SO2) can lead to severe damage of the airways and lung. Naphthalene is a 
volatile, polycyclic aromatic hydrocarbon that can form a flammable vapour and is 
commonly used in synthetic tanning agents (Witschi and Last, 2001). This chemical 
can be found in many different sources, such as tars, petroleum, automobile emissions, 
pesticides, antiseptics, and tobacco smoke (Witschi and Last, 2001, Van Winkle et al., 
2004). In experimental animals, inhaled naphthalene had shown extensive and 
selective necrosis in the subset of club/Clara cells, thus resulting in denudation of the 
distal airway’s basement membrane (Hong et al., 2004b, Hong et al., 2004a, Park et 
al., 2006). Exposure to naphthalene at high concentrations also resulted in damage in 
both distal and proximal airways (West et al., 2001). Besides naphthalene, SO2 is a 
toxic air pollutant from combustion of fossil fuels such as poor-quality coal and 
petroleum. This pollutant can be found in various industrial processes (Li et al., 2014). 
It is commonly notable that SO2 can compromise pulmonary function and aggravate 
respiratory tract diseases such as chronic bronchitis and asthma (Smargiassi et al., 
2009, Chang et al., 2012). SO2 is soluble in water and can easily irritate the mucous 
membranes of the airway upon inhalation (Yang and Omaye, 2009). Studies suggested 
that exposure to SO2 had resulted in pseudostratified epithelium removal in the 
proximal airways (trachea and bronchi) with excessive inflammatory cell infiltration 
and mucus cell hyperplasia (Asmundsson et al., 1973, Sueyoshi et al., 2004, Kodavanti 
et al., 2006). In addition, the SO2 inhalation injury is usually accompanied by the rapid 
onset of a burning of the eyes, nose, and throat (associated with cough, chest pain, 
chest tightness, and dyspnea) (Yang and Omaye, 2009).  
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1.2.2(e) Physical perturbation-induced injury model of ALI 
Injury to the mucosal surface of tracheal epithelium can cause epithelial cell 
shedding and denudation. In the submucosal region, there may be evidence of 
immediate haemorrhage and fibrin clot formation, followed rapidly by oedema and 
neutrophil invasion (Raub et al., 2010). Damage in the tracheobronchial region is 
commonly associated with dyspnea, haemoptysis, emphysema, pneumothorax, and 
pneumomediastinum that cause pulmonary gas exchange abnormalities (Richter and 
Ragaller, 2011). A few studies have demonstrated physical perturbation induced by 
curettage removed the whole intact mucosa (Wilhelm, 1953), whereas perturbation 
using cotton swabs (Hilding, 1965), blunt probe (Gordon and Lane, 1976), and 
stainless steel probe (Keenan et al., 1982) only exfoliated luminal cells and left the 
basal cells intact. Other attempts using apparatus such as cytology brush (Raub et al., 
2010) and nylon brush (Nakagishi et al., 2005, Zani et al., 2008) not only exfoliated 
mucosal epithelium, but also altered the submucosal structure with damaged blood 
vessels and the infiltration of lymphocytic. Raub et al. also demonstrated a deposition 
of fibroblast cells that developed into thickened and granulated mucosal tissue 
following physical scraping with cytology brush (Raub et al., 2010). 
 
1.2.2(f) The cellular response of respiratory airway during ALI 
Immediately after injury, cellular losses within these airway epithelium are 
persistently replenished by stem cells to meet homeostatic needs or regenerative 
demands (Coraux et al., 2005, Rennard and Wachenfeldt, 2011). Basal, secretory, and 
ATII epithelial cells are generally notable for their self-renewal capacity and the ability 
to give rise to other epithelial lineages with a constitutively high rate of cell turnover 
and a well-delineated stem/progenitor cell hierarchy (Hogan et al., 2014, Kotton and 
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Morrisey, 2014). The repair process of airway epithelium started with epithelial cell 
from neighbouring the wound receiving signals from the damage cells. In the trachea 
and bronchi region, for example, the population of basal cells retrieves the signalling 
and respond to injury by cell migration, proliferation, and differentiation processes 
(Yahaya, 2012, Girault and Brochiero, 2014). Cell migration is one of the first 
mechanisms of epithelial repair. In the early repair stage, epithelial cells form a 
multiple layer of flattened epithelial cells (Dupuit et al., 2000, Yahaya, 2012), which 
are associated with cytoskeleton reorganisation, membrane cell elongation, and release 
of adhesion proteins (cadherin, integrin, etc.) along with ECM to facilitate the 
spreading and migration of the cells (Su et al., 2013, Girault and Brochiero, 2014). 
This phase is normally referred to as the epithelial-to-mesenchymal transition (EMT). 
This event is crucial and usually occurs spontaneously during wound healing or tissue 
remodelling (Zeisberg and Neilson, 2009). The EMT involves the transition by which 
non-motile epithelial cells gain motility, migratory, and invasive properties to become 
mesenchymal stem cells (MSCs) (Zeisberg and Neilson, 2009, Lamouille et al., 2014). 
The initiation of the EMT is marked by the phenotype switch from epithelial to 
mesenchymal cell marker (Huang et al., 2012, Lamouille et al., 2014, Nishioka et al., 
2015) to acquire a more motile and mesenchymal phenotype (Zeisberg and Neilson, 
2009, Lamouille et al., 2014). Transforming growth factor-β (TGF-β) is normally 
highly expressed during the EMT to stimulate fibroblast proliferation to increase the 
production of ECM (Araya et al., 2007, Kitamura et al., 2011, Brand et al., 2015). The 
migrated cells then undergo mitosis and proliferate, which are also identified as 
squamous metaplasia (Coraux et al., 2005, Puchelle et al., 2006). Once the epithelial 
barrier is re-established, the epithelial cells within the basal compartment segregate 
into distinct subpopulations that yield ciliated and secretory cells. The cells either 
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undergo ciliogenesis to become ciliated cells or differentiate into secretory cells to 
form the pseudostratified mucociliary epithelium (Coraux et al., 2005, Yahaya, 2012, 
Pardo-Saganta et al., 2015). The rate of respiratory epithelial cell regeneration is varied 
among animal models. In mice, studies have suggested that weeks to months period of 
time is required for epithelial cell to repopulate pseudostratified tracheal epithelium 
layer after chlorine (Musah et al., 2012) and naphthalene injury (Hong et al., 2004b). 
Meanwhile, in lungs, epithelium restoration was completed by day ten after chlorine 
exposure (Tuck et al., 2008) and full recovery of alveolar-capillary barrier dysfunction 
was observed by days 5-10 after HCl-induced injury (Patel et al., 2012). 
 
1.2.2(g) The inflammatory response of respiratory airway during ALI 
Epithelial cells, macrophages, dendritic cells, and mast cells fall in the sensor 
cell category that play role in detecting pathogens and foreign particles within the 
respiratory tract. Sensor cells, as the first tier of defence, immediately initiate innate 
immune responses to clear the local invasion (Iwasaki et al., 2017). These cells release 
first-order cytokines, such as interferon-γ (IFN-γ) and IL-1β that activate local tissue-
resident lymphocytes. IL-1β also stimulates fibroblast proliferation during the airway 
repair to increase the production of ECM, smooth-muscle actin, and a number of 
chemokines and chemoattractant through αvβ8-mediated TGF-β pathway (Araya et 
al., 2007, Kitamura et al., 2011, Brand et al., 2015). IL-1β also activates alveolar 
macrophages to produce variety of chemokines such as IL-8 and MIP-1α (Goodman 
et al., 2003, Grommes and Soehnlein, 2011). IL-8 is defined as a CXC chemokines 
(Vos and Briscoe, 2002) and chemoattractant predominantly for neutrophils 
(Goodman et al., 2003, Matute-Bello et al., 2011) and plays role in promoting 
neutrophils migration into the interstitial and alveolar space by activating endothelial 
